Dapagliflozin DPPIV Inhibitor add-on Study

Completed · Phase 3 · Has a placebo group

Conditions studied: Type 2 Diabetes

In brief

This study aims to investigate how dapagliflozin can control blood sugar in patients with type 2 diabetes when added to existing treatments (sitagliptin alone or in combination with metformin). The effect of dapagliflozin on weight and blood pressure will also be studied.

Key facts

Study ID

NCT00984867

Run by

AstraZeneca

People needed

833

Starts

2009-10-01

Expected to finish

2011-09-01

Last updated by the study team

2014-06-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with type 2 diabetes
• Patients who are not receiving treatment , or those who currently receive metformin, sitagliptin or vildagliptin or the combination of these
• Patients will be screened by a blood test and only those who need additional therapy can be enrolled

You may not qualify if…

• Patients with type 1 diabetes
• Patients with very poorly controlled diabetes
• Any clinically significant illness, which in the judgement of the investigator would compromise the patient's safety or successful participation in the clinical study

Where it is running

• Research Site — Ozark, Alabama, United States
• Research Site — Anaheim, California, United States
• Research Site — Chula Vista, California, United States
• Research Site — Greenbrae, California, United States
• Research Site — Laguna Hills, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — Riverside, California, United States
• Research Site — West Hills, California, United States
• Research Site — Boca Raton, Florida, United States
• Research Site — DeLand, Florida, United States
• Research Site — Jacksonville, Florida, United States
• Research Site — Longwood, Florida, United States
• Research Site — Miami, Florida, United States
• Research Site — Port Orange, Florida, United States
• Research Site — West Palm Beach, Florida, United States
• Research Site — Stone Mountain, Georgia, United States
• Research Site — Wichita, Kansas, United States
• Research Site — Lake Charles, Louisiana, United States
• Research Site — Edina, Minnesota, United States
• Research Site — St Louis, Missouri, United States
• Research Site — Las Vegas, Nevada, United States
• Research Site — Pahrump, Nevada, United States
• Research Site — Staten Island, New York, United States
• Research Site — Wilmington, North Carolina, United States
• Research Site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.